Schroders Cap Glbl - Directorate Change
17/05/2023 16:50
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230517:nRSQ7796Za&default-theme=true
RNS Number : 7796Z Schroders Capital Global Innovation 17 May 2023
Directorate Change
Following a comprehensive selection process, conducted using a third-party
search firm, Schroders Capital Global Innovation Trust plc (the "Company") is
pleased to announce the appointment of Dr Lamia Baker as an independent
non-executive director of the Company with effect from 22 June 2023. She will
also become a member of the Audit, Risk and Valuation, Management Engagement
and Nomination and Remuneration Committees on the same date.
Dr Baker is currently managing director UK of Dennemeyer & Co Limited, a
position she has held since 2019, as well as Head of Commercial EMEA for
Dennemeyer Group a position held since 2022, a global intellectual property
service provider ('Dennemeyer'). Before joining Dennemeyer, Dr Lamia Baker was
Head of Engineering Licensing at Imperial Innovations Ltd, focusing on
commercializing Intellectual Property through licensing activities and startup
formation. This position was preceded by employment as a venture capital seed
investor in high-technology startups in the UK and by various positions in
several technology startups in Boston, USA.
Dr Lamia Baker has over 20 years of experience in business and technology. She
is skilled in IP, innovation, technology transfer, entrepreneurship, venture
capital investment and fund representation on companies' boards.
There is no other information required to be disclosed under section 9.6.13 of
the Listing Rules in respect of Dr Lamia Baker.
As detailed in the Report and Accounts for the year ended 31 December 2022,
Raymond Abbott, who has been a Director since 1 October 2019 will retire at
the conclusion of the forthcoming AGM to be held on 21 June 2023.
Enquiries:
Shilla Pindoria
Schroder Investment Management Limited
Tel: 020 7658 6000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOABUGDUCSBDGXR